Hikma Pharmaceuticals

Hikma names Patrick Genestin to lead generics business development 

Hikma names Patrick Genestin to lead generics business development 

LONDON – Hikma Pharmaceuticals  (Hikma), the multinational pharmaceutical company, announces that Patrick Genestin has been appointed vice president, Business Development, Generics. Genestin brings to Hikma more than 25 years of experience in the pharmaceutical industry as a results-driven  executive with strong financial, business development and M&A experience. He will be based at the company’s U.S. 

Hikma donates over $4 million in medicines and signs new long-term partnerships

Hikma donates over $4 million in medicines and signs new long-term partnerships

LONDON — Hikma Pharmaceuticals has donated over $4 million USD in medicines in 2020 through its global medicine donation program, continuing its long-running commitment to supporting charities that address health issues in underserved communities around the world. Hikma also announces it has extended and increased donation agreements with its existing partners, Dispensary of Hope, Direct Relief and the National Children’s

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane